"Rosuvastatin Reduces Plasma Small Dense Ldl-Cholesterol Predominantly in Non-Diabetic Hypercholesterolemic Patients"
written by Gen Yoshino, Saburo Nakano, Tomoko Matsumoto, Eiichi Murakami, Toshisuke Morita, Koji Kuboki,
published by Pharmacology & Pharmacy, Vol.3 No.1, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] The New Molecular Entity Evolocumab, One Kind of PCSK9 Inhibitor, Reduce Plasma Small Size LDL-Cholesterol Levels by Using a New Standardized Method …
2017
[2] The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: A case series study
2017
[3] The new molecular entity evolocumab, one kind of PCSK9 inhibitor, reduce plasma small size LDL-cholesterol levels by using a new standardized method of …
2017
[4] Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 …
Diabetes Research and Clinical Practice, 2016
[5] Journal of Clinical & Translational Endocrinology
2016
[6] The Association Between Small Dense Low Density Lipoprotein and Coronary Artery Disease in North Indian Patients
Indian Journal of Clinical Biochemistry, 2016
[7] Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in japanese patients with type 2 diabetes mellitus
Journal of Clinical & Translational Endocrinology, 2016
[8] Status of Small Dense LDI in Cardiovascular Disease Subjects Taking Drug Therapy.
International Journal of Health Sciences and Research (IJHSR), 2015
[9] Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 diabetes mellitus
Diabetes research and clinical practice, 2015
[10] Status of Small Dense LDL in Cardiovascular Disease Subjects Taking Drug Therapy
2015
[11] Estimation of Small, Dense LDL Particles Using Equations Derived From Routine Lipid Parameters as Surrogate Markers
Biochem Anal Biochem, 2014
[12] Estimation of Small, Dense LDL Particles Using Equations Derived From Routine Lipid Parameters as Surrogate Markers
Biochemistry & Analytical Biochemistry, 2014
[13] Estimation of Small, Dense LDL Particles Using Equations Derived From Routine Lipid Parameters as Surrogate Markers. Biochem Anal Biochem 3: 146 …
2014